Abstract
Background and Aims: Renal transplant recipients (RTRs) are at high risk of cardio-vascular disease (CVD) mortality which can be predicted by autoantibodies against apolipoprotein A-1 (anti-apoA-1 IgG). Those antibodies seems to be oriented against the c-terminal part of apoA-1 (cterA1). We investigated whether anti-cterA1 IgGs could be associated with CVD or overall mortality, incident graft failure or HDL functionality in RTRs.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have